Terézhalmy 4/7/18

Medical Management of Odontogenic Infections

1. The therapeutic index of an antibacterial agent can be anticipated to be more favorable with which mechanisms of antibacterial action?

2. Unless the patient has an allergy to beta-lactam antibacterial agents, what is the empirical drug of choice for the initial treatment of an odontogenic infection?

3. What are the pharmacological properties characteristic of penicillin V?

4. Which macrolid has an extended spectrum against facultative and some obligate anaerobes, has a once a day dosage schedule, and is the least likely macrolid to produce an adverse drug effect?

5. Which antibacterial agent is an inhibitor of nucleic acid synthesis, is beta- lactamase resistant, and has good activity against oral obligate anaerobes?

6. Which antibacterial agents target bacterial enzymes that synthesize protein from the mRNA code?

7. Which antibacterial agents is the most effective empirical drug of choice for the treatment of an odontogenic infection in an otherwise healthy patient who is allergic (history of anaphylaxis) to beta-lactam antibibacterial agents?

8. When a patient presents with a severe odontogenic infection, what would be your empirical antibacterial drug?

9. Which antibacterial agent sequentially blocks the folate pathway, produces synergism, and is bacteriostatic?

10. Which antibacterial agents are bactericidal?

11. Which antibacterial agents are bacteriostatic?

12. Which beta-lactam antibacterial agent is effective against Gram-positive and Gram-negative organisms, including anaerobes, and is mostly beta-lactamase resistant?

13. What are the characteristics of odontogenic infections and the strategies for the medical management of odontogenic infections?

14. When treating an uncomplicated odontogenic infection with penicillin V and significant improvement is not noted within 48 to 72 hours, the empirical addition of which antibacterial agent is reasonable because it is beta-lactamase resistant.

1 Terézhalmy 4/7/18

15. When a patient presents with an unresolved odontogenic infection following treatment with a full course of a beta-lactam agent, the administration of which antibacterial agent is reasonable because it is beta-lactamase resistant?

16. Many oral Gram-negative anaerobes appear to be inherently resistant to erythromycin (a macrolide) because the structure of the outer bacterial cell membrane restricts entry of the drug. This drug resistance is an example of what type of drug resistance?

17. What are the mechanisms of mutational drug resistance and how are they manifest clinically?

18. What are the various mechanisms responsible for acquired forms of drug resistance?

19. Certain bacteria block ribosomal receptor sites, a mechanism responsible for macrolide resistance, and because macrolid-related microsomal receptor sites overlap with the receptor sites for another antibacterial agent, these bacteria will also be resistant to which other antibacterial agent important to dentists?

20. Certain bacteria may develop macrolide resistance by activating efflux pumps. These activated efflux pumps can also affect the intracellular concentration of what other antibacterial agents?

2